Cellexus chasing emerging bacteriophage sector with new bioreactor
Phage manufacturers are yet to take advantage of single-use techs says Cellexus, which hopes bioreactors employing its ‘air lift’ system will win it customers in this emerging niche.
Phage manufacturers are yet to take advantage of single-use techs says Cellexus, which hopes bioreactors employing its ‘air lift’ system will win it customers in this emerging niche.
Contract manufacturer Emergent BioSolutions and biosimilar developer Pfenex have both announced in recent days that they’ve won contract manufacturing and development grants with the US government.